Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-26

Clinical Trial Update: IN Sub-Dissociative Ketamine vs IN Fentanyl [Phase 2]

View source ↗

Summary

Phase 2 trial comparing intranasal dissociative ketamine to intranasal fentanyl for bone fracture analgesia has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intranasal fentanyl (fentanyl)
  • intranasal dissociative ketamine

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Bone Fracture | Phase 2 | Status: COMPLETED | Results posted: 2022-07-26